Hepatitis B virus surface antigen as a mucosal immunostimulator and the resulting formulations

Details for Australian Patent Application No. 2003210123 (hide)

Owner Centro de Ingenieria Genetica y Biotecnologia

Inventors Aleman Zaldivar, Regis; Aguilar Rubido, Julio Cesar; Hardy Rando, Eugenio; Sardinas Garcia, Gretel; Guillen Nieto, Gerardo Enrique; Alvarez Obregon, Julio Cesar; Urquiza Noa, Dioslaida; Lobaina Mato, Yadira; Pajon Feyt, Rolando; Garcia Gonzalez, Daymir; Penton Arias, Eduardo; Muzio Gonzalez, Verena Lucila; Iglesias Perez, Enrique

Agent Shelston IP

Pub. Number AU-B-2003210123

PCT Number PCT/CU03/00001

PCT Pub. Number WO2003/061692

Priority 2002-0019 24.01.02 CU

Filing date 22 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 1 March 2007

International Classifications

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 2002-0019 24.01.02 CU

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003210123

1 March 2007 Application Accepted

  Published as AU-B-2003210123

28 June 2007 Standard Patent Sealed

20 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003210124-METHOD OF STIMULATING GROWTH AND RESISTANCE TO DISEASES OF AQUATIC ORGANISMS

2003210122-ORAL DNA COMPOSITION FOR HEPATITIS B VIRUS CHRONIC INFECTION